Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Anavex Lf SC
(NQ:
AVXL
)
2.910
USD
-0.120 (-3.96%)
Official Closing Price
/ Updated:
7:55 PM EST, Dec 5, 2019
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
2,691,500
Open
3.210
Bid (Size)
2.750 (5)
Ask (Size)
2.840 (4)
Prev. Close
3.030
Today's Range
2.710 - 3.450
52wk Range
1.250 - 4.090
Shares Outstanding
44,660,062
Dividend Yield
N/A
Performance
YTD
+73.21%
+73.21%
1 Month
+7.38%
+7.38%
3 Month
+9.81%
+9.81%
6 Month
-2.35%
-2.35%
1 Year
+31.67%
+31.67%
Top News
More News
Anavex Life Sciences Presents ANAVEX®2-73 (blarcamesine) Data at 12th Clinical Trials on Alzheimer's Disease (CTAD) 2019 Conference
December 04, 2019
from
GlobeNewswire News Releases
Top Penny Stocks To Watch On Thursday
December 05, 2019
from
Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
More News
Read More
Anavex Life Sciences Receives Rare Pediatric Disease Designation from FDA for ANAVEX®2-73 (blarcamesine) for the Treatment of Rett Syndrome
November 14, 2019
from
GlobeNewswire News Releases
Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 (blarcamesine) in Rett Syndrome
November 06, 2019
from
GlobeNewswire News Releases
Anavex Life Sciences Announces ATTENTION-AD ANAVEX®2-73 Extension Clinical Study in Early Alzheimer’s Disease
October 09, 2019
from
GlobeNewswire News Releases
Anavex Life Sciences Issued New U.S. Patent for Composition of Matter Covering ANAVEX®2-73 for the Treatment of Alzheimer’s Disease
October 02, 2019
from
GlobeNewswire News Releases
Anavex Life Sciences Presented at the 6th Annual European Rett Syndrome Conference Preliminary Clinical Efficacy Data from the U.S. Rett Syndrome Phase 2 ANAVEX®2-73 Study
September 27, 2019
from
GlobeNewswire News Releases
Anavex Life Sciences to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
September 26, 2019
from
GlobeNewswire News Releases
Anavex Life Sciences to Present at the Ladenburg Thalmann 2019 Healthcare Conference
September 18, 2019
from
GlobeNewswire News Releases
Anavex Life Sciences Announces Preliminary Clinical Efficacy Data of its U.S. Phase 2 Clinical Trial of ANAVEX®2-73 in Patients with Rett Syndrome
September 16, 2019
from
GlobeNewswire News Releases
12 Healthcare Stocks Moving In Wednesday's Pre-Market Session
December 04, 2019
category
LCI
,
General
,
Movers
, and 20 more.
from
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.